A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B
NCT05828745 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-05-21
Summary
CB06-036 is an investigational drug developed by Shanghai Zhimeng Biopharma Inc. for the treatment of Chronic Hepatitis B.
Conditions
Interventions
- DRUG
-
CB06-036
CB06-036 capsule
- DRUG
-
Placebo capsule
Sponsors & Collaborators
-
Shanghai Zhimeng Biopharma, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-22
- Primary Completion
- 2025-02-18
- Completion
- 2025-02-18
Countries
- China
- New Zealand
Study Locations
More Related Trials
-
A Study of RBD1016 in CHB Participants
NCT05961098 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
NCT06829329 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety, Tolerability Phase Ia Study of XT1061 in Single and Multiple Doses in Healthy Subjects
NCT06280534 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis B
NCT05256823 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B
NCT05808374 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B Patients
NCT04480294 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B
NCT06452693 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults
NCT07059403 ·Status: RECRUITING ·Phase: PHASE1
-
Treatment and Prognosis of Patients With Chronic HBV Infection
NCT05392387 ·Status: RECRUITING
-
A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B
NCT04112147 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment
NCT03615066 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
NCT06263959 ·Status: RECRUITING ·Phase: PHASE2
-
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
NCT06680232 ·Status: RECRUITING ·Phase: PHASE1
-
A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy
NCT05276297 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine
NCT02693652 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients
NCT01487876 ·Status: UNKNOWN ·Phase: PHASE2
-
A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection
NCT05017116 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)
NCT04449029 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
NCT06311734 ·Status: COMPLETED ·Phase: PHASE1
-
Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis B
NCT03429439 ·Status: UNKNOWN ·Phase: NA
-
Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced Cirrhosis
NCT03437876 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis B
NCT01189656 ·Status: UNKNOWN ·Phase: PHASE2
-
A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7049389 in Healthy Chinese Participants
NCT03570658 ·Status: COMPLETED ·Phase: PHASE1
-
Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
NCT02883647 ·Status: RECRUITING
-
A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine
NCT04289987 ·Status: COMPLETED ·Phase: PHASE2